The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Medac Gesellschaft Fur Klinische competitive analysis

Loading summary...

Latest oppositions filed by Medac Gesellschaft Fur Klinische

Explore patent oppositions filed by Medac Gesellschaft Fur Klinische against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Nov 13, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP2478907
Methods And Compositions For Treating CancerCOUGAR BIOTECHNOLOGYJan 11, 2022
EP2493466
Novel Antitumoral Use Of CabazitaxelAVENTIS PHARMAMar 22, 2021
EP3294285
Cabazitaxel And Its Use For Treating CancerAVENTIS PHARMASep 18, 2020

Latest PTAB cases involving Medac Gesellschaft Fur Klinische

Discover the latest PTAB cases involving Medac Gesellschaft Fur Klinische, highlighting their recent legal challenges and patent disputes.

Last updated on: Nov 14, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Medac Gesellschaft Fur Klinische

IPR2014-01091Jul 1, 2014ANTARES PHARMAMEDAC GESELLSCHAFT FUR KLINISCHETerminated-Settled

Peer Comparison New

IP litigation analysis comparing Medac Gesellschaft Fur Klinische with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
MEDAC GESELLSCHAFT FUR KLINISCHE SPEZIALPRAPARATE3 - - -
AVENTIS PHARMA - 24 - 3
COUGAR BIOTECHNOLOGY - 22 - -
SANOFI MATURE - 24 - -